{
    "code": "10000746",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=10000746",
    "time": "2018-01-12 03:21:38",
    "許可證字號": "衛署菌疫輸字第000746號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "106\/12\/11",
    "發證日期": "91\/12\/11",
    "許可證種類": "菌　疫",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA01000074602",
    "中文品名": "威保 50U\/ml 抗抑制子凝血複合物",
    "英文品名": "FEIBA 50U\/ml",
    "適應症": "治療帶有抑制子之A型血友病患者的出血。\r\n治療帶有抑制子之B型血友病患者的出血。\r\n治療有後天性第八因子抗體之非血友病患者的出血。\r\n預防曾有嚴重出血或具高度重大出血風險之帶有抑制子A型血友病患者的出血。",
    "劑型": "243凍晶注射劑",
    "包裝": "1000U 20ML, 附20小瓶附溶液及輸注器",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "主成分略述": [
        "HUMANPLASMAPROTEINWITHFACTORVIIIINHIBITORBYPASSINGACTIVITY"
    ],
    "限制項目": "02輸　入",
    "申請商名稱": "620117O956  夏爾生技醫藥股份有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "F030018000  BAXTER AG",
        "製造廠廠址": "INDUSTRIESTRASSES 67, A-1220 WIEN, AUSTRIA.",
        "製造廠公司地址": ""
    },
    "CCC號列": "30021040002 抗血友病製劑Antihemophilia preparations",
    "藥理治療分類": "",
    "次製造廠": [
        {
            "製造廠名稱": "F470367000  HAMELN PHARMACEUTICALS GMBH",
            "製造廠廠址": "LANGES FELD 13, 31789 HAMELN, GERMANY",
            "製造廠公司地址": "",
            "製造廠國別": "GERMANY",
            "製程": "稀釋液"
        }
    ],
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "8004000720",
            "成分名稱": "HUMAN PLASMA PROTEIN WITH FACTOR VIII INHIBITOR BY PASSING ACTIVITY",
            "含量描述": "(400-1200)",
            "含量": "0.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "000746-106-03-31.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000746&Seq=012&Type=9"
        },
        {
            "title": "衛署菌疫輸000746外盒包裝、標籤-105-03-17.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000746&Seq=007&Type=8"
        }
    ]
}